Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2006 3
2007 1
2008 4
2009 3
2010 4
2011 6
2012 1
2013 3
2014 1
2015 3
2016 1
2017 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Results by year
Filters applied: . Clear all
Page 1
Methylselenocysteine preventing castration-resistant progression of prostate cancer.
Liu Y, Liu X, Guo Y, Liang Z, Tian Y, Lu L, Zhao X, Sun Y, Zhao X, Zhang H, Dong Y. Liu Y, et al. Prostate. 2015 Jun 15;75(9):1001-8. doi: 10.1002/pros.22987. Epub 2015 Mar 8. Prostate. 2015. PMID: 25754033 Free PMC article.
Here we investigated the ability of methylselenocysteine to inhibit castration-resistant progression of prostate cancer. ...CONCLUSIONS: The present study represents the first to show the preclinical efficacy of methylselenocysteine in delaying castration-res …
Here we investigated the ability of methylselenocysteine to inhibit castration-resistant progression of prostate cancer. ...CO …
Se-methylselenocysteine suppresses the growth of prostate cancer cell DU145 through connexin 43-induced apoptosis.
Lu Z, Qi L, Li GX, Bo XJ, Liu GD, Wang JM. Lu Z, et al. J Cancer Res Ther. 2015 Oct-Dec;11(4):840-5. doi: 10.4103/0973-1482.139265. J Cancer Res Ther. 2015. PMID: 26881528 Free article.
CONTEXT: Se-methylselenocysteine (MSC), as a chemopreventive agent, shows antitumor effects in some cancer models, but its mechanism is still unclear. AIMS: This study is to explore whether MSC induces apoptosis in prostate cancer (PCa) cells DU145 through connexin …
CONTEXT: Se-methylselenocysteine (MSC), as a chemopreventive agent, shows antitumor effects in some cancer models, but its mechanism …
Combination effects of dietary soy and methylselenocysteine in a mouse model of prostate cancer.
Christensen MJ, Quiner TE, Nakken HL, Lephart ED, Eggett DL, Urie PM. Christensen MJ, et al. Prostate. 2013 Jun;73(9):986-95. doi: 10.1002/pros.22646. Epub 2013 Feb 6. Prostate. 2013. PMID: 23389815 Free PMC article.
BACKGROUND: High dietary intake of soy or selenium (Se) is associated with decreased risk of prostate cancer. Soy constituents and various chemical forms of Se have each been shown to downregulate expression of the androgen receptor (AR) and AR-regulated genes in the pr
BACKGROUND: High dietary intake of soy or selenium (Se) is associated with decreased risk of prostate cancer. Soy constituents and va …
Production of Se-methylselenocysteine in transgenic plants expressing selenocysteine methyltransferase.
Ellis DR, Sors TG, Brunk DG, Albrecht C, Orser C, Lahner B, Wood KV, Harris HH, Pickering IJ, Salt DE. Ellis DR, et al. BMC Plant Biol. 2004 Jan 28;4:1. doi: 10.1186/1471-2229-4-1. BMC Plant Biol. 2004. PMID: 15005814 Free PMC article.
BACKGROUND: It has become increasingly evident that dietary Se plays a significant role in reducing the incidence of lung, colorectal and prostate cancer in humans. Different forms of Se vary in their chemopreventative efficacy, with Se-methylselenocysteine being on …
BACKGROUND: It has become increasingly evident that dietary Se plays a significant role in reducing the incidence of lung, colorectal and …
The mechanism of methylselenocysteine and docetaxel synergistic activity in prostate cancer cells.
Azrak RG, Frank CL, Ling X, Slocum HK, Li F, Foster BA, Rustum YM. Azrak RG, et al. Mol Cancer Ther. 2006 Oct;5(10):2540-8. doi: 10.1158/1535-7163.MCT-05-0546. Mol Cancer Ther. 2006. PMID: 17041098 Free PMC article.
The study was designed to evaluate the combination treatment of methylselenocysteine (MSeC) and docetaxel and to delineate the underlying mechanism associated with observed in vitro synergy between MSeC and docetaxel in prostate cancer cells. ...In conclusion, pretr …
The study was designed to evaluate the combination treatment of methylselenocysteine (MSeC) and docetaxel and to delineate the underl …
Mouse prostate proteomes are differentially altered by supranutritional intake of four selenium compounds.
Zhang J, Wang L, Li G, Anderson LB, Xu Y, Witthuhn B, Lü J. Zhang J, et al. Nutr Cancer. 2011;63(5):778-89. doi: 10.1080/01635581.2011.563029. Epub 2011 Jun 1. Nutr Cancer. 2011. PMID: 21614726
We have shown that, in contrast to selenomethionine (SeMet) or selenite, methylseleninic acid (MSeA) and Se-methylselenocysteine (MSeC) exert prostate cancer (PCa) inhibitory effect in preclinical models. ...We propose that the balance of oncogenic vs. suppressor pr …
We have shown that, in contrast to selenomethionine (SeMet) or selenite, methylseleninic acid (MSeA) and Se-methylselenocysteine (MSe …
Se-methylselenocysteine alters collagen gene and protein expression in human prostate cells.
Hurst R, Elliott RM, Goldson AJ, Fairweather-Tait SJ. Hurst R, et al. Cancer Lett. 2008 Sep 28;269(1):117-26. doi: 10.1016/j.canlet.2008.04.025. Epub 2008 Jun 2. Cancer Lett. 2008. PMID: 18514395
The anti-cancer activity of selenium is dose-dependent and species-specific but the mechanism is unclear. Se-methylselenocysteine (MSC), found in selenium-enriched alliums, is one of the most potent forms. We exposed two human prostate cell lines (LNCaP clone FGC an …
The anti-cancer activity of selenium is dose-dependent and species-specific but the mechanism is unclear. Se-methylselenocysteine (MS …
Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.
Liu X, Gao R, Dong Y, Gao L, Zhao Y, Zhao L, Zhao X, Zhang H. Liu X, et al. BMC Cancer. 2010 Aug 10;10:418. doi: 10.1186/1471-2407-10-418. BMC Cancer. 2010. PMID: 20698994 Free PMC article.
METHODS: Expression of survivin was analyzed in a collection of normal and malignant prostatic tissues by immunohistochemical staining. In vitro studies were conducted in PC-3M, C4-2B, and 22Rv1 prostate cancer cells. ...RESULTS: We found that survivin was undetecta …
METHODS: Expression of survivin was analyzed in a collection of normal and malignant prostatic tissues by immunohistochemical stainin …
Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit.
Wang L, Bonorden MJ, Li GX, Lee HJ, Hu H, Zhang Y, Liao JD, Cleary MP, Lü J. Wang L, et al. Cancer Prev Res (Phila). 2009 May;2(5):484-95. doi: 10.1158/1940-6207.CAPR-08-0173. Epub 2009 Apr 28. Cancer Prev Res (Phila). 2009. PMID: 19401524 Free PMC article.
Here we used the transgenic adenocarcinoma mouse prostate (TRAMP) model to establish the efficacy of methylseleninic acid (MSeA) and methylselenocysteine (MSeC) against prostate carcinogenesis and to characterize potential mechanisms. ...Therefore, these sele …
Here we used the transgenic adenocarcinoma mouse prostate (TRAMP) model to establish the efficacy of methylseleninic acid (MSeA) and …
Selenium Biomarkers in Prostate Cancer Cell Lines and Influence of Selenium on Invasive Potential of PC3 Cells.
Hendrickx W, Decock J, Mulholland F, Bao Y, Fairweather-Tait S. Hendrickx W, et al. Front Oncol. 2013 Sep 23;3:239. doi: 10.3389/fonc.2013.00239. eCollection 2013. Front Oncol. 2013. PMID: 24066278 Free PMC article.
., glutathione peroxidase 1 (GPx1) and thioredoxin reductase 1 (TrxR1), to determine appropriate selenium levels for in vitro work. Furthermore, we investigated the effects of Se-methylselenocysteine (SeMSC) on prostate cancer cell migration and invasion. After excl …
., glutathione peroxidase 1 (GPx1) and thioredoxin reductase 1 (TrxR1), to determine appropriate selenium levels for in vitro work. Furtherm …
32 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback